These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17456873)

  • 81. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine.
    Cho YD; Yum HY; Park YH
    J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
    Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
    Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
    Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
    HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI
    Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472
    [TBL] [Abstract][Full Text] [Related]  

  • 86. I-131-Lipiodol therapy in liver neoplasms.
    Risse JH; Grünwald F; Strunk H; Kleinschmidt R; Bender H; Biersack HJ
    Hybridoma; 1999 Feb; 18(1):83-5. PubMed ID: 10211793
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
    Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
    Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
    [TBL] [Abstract][Full Text] [Related]  

  • 88. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
    Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
    Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry.
    Risse JH; Pauleit D; Palmedo H; Bender H; Bucerius J; Ezziddin S; Klein V; Grünwald F; Biersack HJ; Reichmann K
    Nuklearmedizin; 2007; 46(5):192-7. PubMed ID: 17938753
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.
    Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Radiofrequency ablation after arterial injection of miriplatin-iodized oil suspension into swine liver: ablative zone size and tissue platinum concentration.
    Yamanaka T; Takaki H; Nakatsuka A; Uchida K; Junji U; Fujimori M; Hasegawa T; Yoneda M; Shiraishi T; Sakuma H; Yamakado K
    Cardiovasc Intervent Radiol; 2014 Aug; 37(4):1047-52. PubMed ID: 24232037
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Safety and efficacy of
    Xiang Z; Bai M; Li G; Zou B; Zhong Z; Gao F; Wu C; Huang M; Zhang F
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1907-1916. PubMed ID: 31161374
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Imaging, biodistribution and efficacy evaluation of
    Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
    Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
    Urata K; Matsumata T; Kamakura T; Hasuo K; Sugimachi K
    J Surg Oncol; 1994 May; 56(1):54-8. PubMed ID: 8176943
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Distribution of iodized oil within the liver after hepatic arterial injection.
    Miller DL; O'Leary TJ; Girton M
    Radiology; 1987 Mar; 162(3):849-52. PubMed ID: 3027747
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology.
    Kurokohchi K; Deguchi A; Masaki T; Himoto T; Yoneyama H; Kobayashi M; Maeta T; Kiuchi T; Kohi F; Miyoshi H; Taminato T; Kuriyama S
    World J Gastroenterol; 2007 Aug; 13(32):4398-400. PubMed ID: 17708619
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling.
    Taniguchi H; Daidoh T; Shioaki Y; Takahashi T
    Cancer; 1993 Jan; 71(1):50-5. PubMed ID: 8380121
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol.
    Banka VK; Moon SH; Jeong JM; Seelam SR; Lee YS; Kim YJ; Lee DS; Chung JK
    Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Therapeutic aspects of radio-isotopes in hepatobiliary malignancy.
    Novell JR; Hilson A; Hobbs KE
    Br J Surg; 1991 Aug; 78(8):901-6. PubMed ID: 1655152
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    Kumar N; Gupta P; Shamim SA; Chirayil V; Subramanian S; Mallia MB; Bal C
    World J Nucl Med; 2023 Jun; 22(2):114-123. PubMed ID: 37223628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.